Preschool assessment of preterm infants treated with darbepoetin and erythropoietin

Pediatrics

Volumn 137, Issue 3, 2016, Pages

  Ohls, Robin K ^a   Cannon, Daniel C ^a   Phillips, John ^a   Caprihan, Arvind ^b   Patel, Shrena ^c   Winter, Sarah ^c   Steffen, Michael ^d   Yeo, Ronald A ^e   Campbell, Richard ^a   Wiedmeier, Susan ^c   Baker, Shawna ^f   Gonzales, Sean ^b   Lowe, Jean ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b MIND RESEARCH NETWORK   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UTAH DEPARTMENT OF HEALTH   (United States)

^e UNIVERSITY OF NEW MEXICO   (United States)

^f UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO; ANTIANEMIC AGENT;

ARTICLE; CHILD; COGNITIVE DEFECT; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; INHIBITION (PSYCHOLOGY); INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS OF VARIANCE; NEUROPROTECTION; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPATIAL MEMORY; TASK PERFORMANCE; TREATMENT OUTCOME; WECHSLER PRESCHOOL AND PRIMARY SCALE OF INTELLIGENCE; WORKING MEMORY; CHILD DEVELOPMENT; CLINICAL TRIAL; COGNITION; COMBINATION DRUG THERAPY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; INFANT; INFANT, PREMATURE, DISEASES; MULTICENTER STUDY; NEURODEVELOPMENTAL DISORDERS; NEWBORN; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TIME FACTOR;

CHILD DEVELOPMENT; CHILD, PRESCHOOL; COGNITION; DARBEPOETIN ALFA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; HEMATINICS; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INJECTIONS, SUBCUTANEOUS; MALE; NEURODEVELOPMENTAL DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84960155642     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-3859     Document Type: Article

References (34)

1. Zhang L, Chopp M, Zhang RL, et al. Erythropoietin amplifies strokeinduced oligodendrogenesis in the rat. 2010 5(6):e11016:1-8
2. Iwai M, Stetler RA, Xing J, et al. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke. 2010;41(5):1032-1037
3. Juul SE, Beyer RP, Bammler TK, McPherson RJ, Wilkerson J, Farin FM. Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus. Pediatr Res. 2009;65(5):485-492
4. Chattopadhyay A, Choudhury TD, Bandyopadhyay D, Datta AG. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol. 2000;59(4):419-425
5. Vairano M, Dello Russo C, Pozzoli G, et al. Erythropoietin exerts antiapoptotic effects on rat microglial cells in vitro. Eur J Neurosci. 2002;16(4):584-592
6. Sugawa M, Sakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H. Effects of erythropoietin on glial cell development: oligodendrocyte maturation and astrocyte proliferation. Neurosci Res. 2002;44(4):391-403
7. Jantzie LL, Miller RH, Robinson S. Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxicischemic brain injury. Pediatr Res. 2013;74(6):658-667
8. Jantzie LL, Getsy PM, Firl DJ, Wilson CG, Miller RH, Robinson S. Erythropoietin attenuates loss of potassium chloride co-transporters following prenatal brain injury. Mol Cell Neurosci. 2014;61(Jul):152-162
9. Jantzie LL, Corbett CJ, Firl DJ, Robinson S. Postnatal erythropoietin mitigates impaired cerebral cortical development following subplate loss from prenatal hypoxia-ischemia. Cereb Cortex. 2015;25(9):2683-2695
10. Ohls RK, Christensen RD, Kamath-Rayne BD, et al. A randomized, masked, placebo controlled study of darbepoetin administered to preterm infants. Pediatrics. 2013;132 (1). Available at: www.pediatrics.org/cgi/content/full/132/1/e119
11. Bayley N. Bayley Scales of Infant and Toddler Development. 3rd ed. San Antonio, TX: Harcourt Assessment; 2006
12. Ohls RK, Kamath-Rayne BD, Christensen RD, et al. Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo. Pediatrics. 2014;133(6):1023-1030
13. Wechsler D. The Wechsler Preschool and Primary Scale of Intelligence. 3rd ed. San Antonio, TX: The Psychological Corporation; 2002
14. Vicari S, Caravale B, Carlesimo GA, Casadei AM, Allemand F. Spatial working memory deficits in children at ages 3-4 who were low birth weight. Neuropsychology. 2004;18(4):673-678
15. Carlson SM. Developmentally sensitive measures of executive function in preschool children. Dev Neuropsychol. 2005;28(2):595-616
16. Fauchère JC, Koller BM, Tschopp A, Dame C, Ruegger C, Bucher HU; Swiss Erythropoietin Neuroprotection Trial Group. Safety of early highdose recombinant erythropoietin for neuroprotection in very preterm infants. J Pediatr. 2015;167(1):52-7
17. Leuchter RH, Gui L, Poncet A, et al. Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age. JAMA. 2014;312(8):817-824
18. O'Gorman RL, Bucher HU, Held U, Koller BM, Hüppi PS, Hagmann CF; Swiss EPO Neuroprotection Trial Group. Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants. Brain. 2015;138(pt 2):388-397
19. Wu YW, Bauer LA, Ballard RA, et al. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics. 2012;130(4):683-691
20. Rogers EE, Bonifacio SL, Glass HC, et al. Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy. Pediatr Neurol. 2014;51(5):657-662
21. Baserga MC, Beachy JC, Roberts JK, et al. Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial. Pediatr Res. 2015;78(3):315-322
22. Bierer R, Peceny MC, Hartenberger CH, Ohls RK. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics. 2006;118 (3). Available at: www.pediatrics.org/cgi/content/full/118/3/e635
23. Brown MS, Eichorst D, Lala-Black B, Gonzalez R. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics. 2009;124 (4). Available at: www.pediatrics.org/cgi/content/full/124/4/e681
24. Neubauer AP, Voss W, Wachtendorf M, Jungmann T. Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann Neurol. 2010;67(5):657-666
25. McAdams RM, McPherson RJ, Mayock DE, Juul SE. Outcomes of extremely low birth weight infants given early high-dose erythropoietin. J Perinatol. 2013;33(3):226-230
26. Phillips JP, Montague EQ, Aragon M, et al. Prematurity affects cortical maturation in early childhood. Pediatr Neurol. 2011;45(4):213-219
27. Anderson PJ, Doyle LW. Cognitive and educational deficits in children born extremely preterm. Semin Perinatol. 2008;32(1):51-58
28. Mulder H, Pitchford NJ, Hagger MS, Marlow N. Development of executive function and attention in preterm children: a systematic review. Dev Neuropsychol. 2009;34(4):393-421
29. Woodward LJ, Clark CA, Pritchard VE, Anderson PJ, Inder TE. Neonatal white matter abnormalities predict global executive function impairment in children born very preterm. Dev Neuropsychol. 2011;36(1):22-41
30. Lowe JR, Duncan AF, Bann CM, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early working memory as a racially and ethnically neutral measure of outcome in extremely preterm children at 18-22 months. Early Hum Dev. 2013;89(12):1055-1061
31. Aarnoudse-Moens CS, Oosterlaan J, Duivenvoorden HJ, Van Goudoever JB, Weisglas-Kuperus N. Development of preschool and academic skills in children born very preterm. J Pediatr. 2011;158(1):51-56
32. Warwood TL, Ohls RK, Lambert DK, et al. Uninary excretion of darbepoetin after intravenous vs subcutaneous administration to preterm infants. J Perinatol. 2006;26(10):636-639
33. Warwood TL, Ohls RK, Lambert DK, et al. Intravenous administration of darbepoetin to NICU patients. J Perinatol. 2006;26(5):296-300
34. Patel S, Ohls RK. Darbepoetin administration in term and preterm neonates. Clin Perinatol. 2015;42(3):557-566